190 related articles for article (PubMed ID: 15878493)
1. The Medical Research Council dyspnea scale in the estimation of disease severity in idiopathic pulmonary fibrosis.
Papiris SA; Daniil ZD; Malagari K; Kapotsis GE; Sotiropoulou C; Milic-Emili J; Roussos C
Respir Med; 2005 Jun; 99(6):755-61. PubMed ID: 15878493
[TBL] [Abstract][Full Text] [Related]
2. The Medical Research Council chronic dyspnea score predicts the survival of patients with idiopathic pulmonary fibrosis.
Manali ED; Stathopoulos GT; Kollintza A; Kalomenidis I; Emili JM; Sotiropoulou C; Daniil Z; Roussos C; Papiris SA
Respir Med; 2008 Apr; 102(4):586-92. PubMed ID: 18162388
[TBL] [Abstract][Full Text] [Related]
3. CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis.
Daniil Z; Kitsanta P; Kapotsis G; Mathioudaki M; Kollintza A; Karatza M; Milic-Emili J; Roussos C; Papiris SA
Respir Res; 2005 Jul; 6(1):81. PubMed ID: 16042790
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis.
Daniil ZD; Papageorgiou E; Koutsokera A; Kostikas K; Kiropoulos T; Papaioannou AI; Gourgoulianis KI
Pulm Pharmacol Ther; 2008; 21(1):26-31. PubMed ID: 17161968
[TBL] [Abstract][Full Text] [Related]
5. [Dyspnea, respiratory mechanics and gas exchange in patients with idiopathic pulmonary fibrosis].
Wesołowski S; Meleniewska-Maciszewska A; Korzeniewska-Koseła M; Kuś J; Radwan L
Pneumonol Alergol Pol; 1997; 65(3-4):220-4. PubMed ID: 9489418
[TBL] [Abstract][Full Text] [Related]
6. Dyspnea scales as a measure of health-related quality of life in patients with idiopathic pulmonary fibrosis.
Baddini Martinez JA; Martinez TY; Lovetro Galhardo FP; de Castro Pereira CA
Med Sci Monit; 2002 Jun; 8(6):CR405-10. PubMed ID: 12070430
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests.
Tzanakis N; Samiou M; Lambiri I; Antoniou K; Siafakas N; Bouros D
Eur J Intern Med; 2005 Apr; 16(2):105-112. PubMed ID: 15833676
[TBL] [Abstract][Full Text] [Related]
8. [The evaluation of dyspnea and quality of life in COPD].
Demir G; Akkoca O; Doğan R; Saryal S; Karabiyikoğlu G
Tuberk Toraks; 2003; 51(4):365-72. PubMed ID: 15143383
[TBL] [Abstract][Full Text] [Related]
9. Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis.
Gvozdenovic BS; Mihailovic-Vucinic V; Ilic-Dudvarski A; Zugic V; Judson MA
Respir Med; 2008 Nov; 102(11):1636-42. PubMed ID: 18691860
[TBL] [Abstract][Full Text] [Related]
10. Functional predictors of exertional dyspnea, 6-min walking distance and HRCT fibrosis score in idiopathic pulmonary fibrosis.
Mura M; Ferretti A; Ferro O; Zompatori M; Cavalli A; Schiavina M; Fabbri M
Respiration; 2006; 73(4):495-502. PubMed ID: 16484770
[TBL] [Abstract][Full Text] [Related]
11. Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis.
Kozu R; Jenkins S; Senjyu H
Respirology; 2011 Nov; 16(8):1196-202. PubMed ID: 21810145
[TBL] [Abstract][Full Text] [Related]
12. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
Kömüs N; Tertemiz KC; Sevinç C
Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor?
Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Ogawa T; Watanabe F; Nishimura K
Respir Med; 2005 Apr; 99(4):408-14. PubMed ID: 15763446
[TBL] [Abstract][Full Text] [Related]
14. [A retrospective cohort study of prognostic factors for death in patients with idiopathic pulmonary fibrosis].
Li ZH; Peng SC; Kang J; Hou XM; Yu RJ
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Dec; 33(12):887-91. PubMed ID: 21211406
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of activity limitation in patients with idiopathic pulmonary fibrosis grouped according to Medical Research Council dyspnea grade.
Kozu R; Jenkins S; Senjyu H
Arch Phys Med Rehabil; 2014 May; 95(5):950-5. PubMed ID: 24502840
[TBL] [Abstract][Full Text] [Related]
16. Determinants of health-related quality of life in patients with pulmonary emphysema.
González E; Herrejón A; Inchaurraga I; Blanquer R
Respir Med; 2005 May; 99(5):638-44. PubMed ID: 15823463
[TBL] [Abstract][Full Text] [Related]
17. The relationship of dyspnoea to function and quality of life in systemic sclerosis.
Baron M; Sutton E; Hudson M; Thombs B; Markland J; Pope J; Robinson D; Jones N; Docherty P; Abu-Hakima M; LeClercq S; Smith D; Mathieu JP
Ann Rheum Dis; 2008 May; 67(5):644-50. PubMed ID: 17728334
[TBL] [Abstract][Full Text] [Related]
18. [Clinical presentation of own idiopathic pulmonary fibrosis patients according to international consensus statement].
Wesołowski S; Kuś J; Oniszh K; Langfort R
Pneumonol Alergol Pol; 2001; 69(11-12):635-43. PubMed ID: 12134439
[TBL] [Abstract][Full Text] [Related]
19. Dyspnoea at 6-min walk test in idiopathic pulmonary fibrosis: comparison with COPD.
Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Ogawa T; Watanabe F; Arizono S
Respir Med; 2007 Apr; 101(4):833-8. PubMed ID: 16962758
[TBL] [Abstract][Full Text] [Related]
20. [Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis with inspiratory muscle training].
Jastrzebski D; Kozielski J; Zebrowska A
Pneumonol Alergol Pol; 2008; 76(3):131-41. PubMed ID: 18843927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
